# ClinicalTrials.gov record history: NCT02049034

- Peptide profile: [lixisenatide](https://peptidescanner.com/peptides/lixisenatide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct02049034-lixisenatide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct02049034.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `07ddda8b42780e282b9dec532d581cbeb81f187e4423eeeb042f06ff75c14873`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2014-01-27 | 2014-01-27 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02049034?a=1&tab=history) | `a8bbcfc3685fe4d238ed62962a80013a28eeaec082bfe2bb5eeb924c522a794f` |
| 2 | 2015-10-05 | 2015-10-05 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02049034?a=2&tab=history) | `eef7c6029bb77ace826a76442a2a7df9ef6c111ada62ebce5b8bbc88264e87e2` |
| 3 | 2016-02-15 | 2016-02-15 | COMPLETED | INTERVENTIONAL | Contacts/Locations, Eligibility, Outcome Measures, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02049034?a=3&tab=history) | `58e5d0229d16a0c2c9139b5b098f17124b397add17f3810b75b4b695af8d1c9a` |
| 4 | 2016-06-02 | 2016-06-02 | COMPLETED | INTERVENTIONAL | IPDSharing, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02049034?a=4&tab=history) | `a08a88079b6dfb7e6699974d20c860c8dafa8ebfc0b45ddaa5820fd8c0cdd066` |
| 5 | 2024-04-24 | 2024-04-24 | COMPLETED | INTERVENTIONAL | IPDSharing, References, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02049034?a=5&tab=history) | `a9a9a5bf7d823e4a8de7db81489f74ab7e1bd5bdcbc1955ec4f8ba596a00d305` |
| 6 | 2024-12-11 | 2024-12-11 | COMPLETED | INTERVENTIONAL | Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02049034?a=6&tab=history) | `09e3f69ad979601c88292cf997b9acd9cb9c368caef6179b3eef1e920db3b7ba` |